Zobrazeno 1 - 10
of 50
pro vyhledávání: '"L G Fechina"'
Autor:
Y Y DYAKONOVA, O I BYDANOV, A M POPOV, Y V OLSHANSKAYA, E G BOICHENKO, O V ALEYNIKOVA, M A MASCHAN, L N SHELIKHOVA, D V LITVINOV, L A KHACHATRYAN, N I PONOMAREVA, L G FECHINA, G A NOVICHKOVA, E D PASHANOV, A I KARACHUNSKIY
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 37-50 (2018)
Aim. The analysis of experience of nelarabine use in refractory/relapsed T-cell acute lymphoblastic leukemia (T-ALL) depending on the immunophenotype and the line of therapy. Materials and methods. All the patients with relapsed or refractory T-ALL a
Externí odkaz:
https://doaj.org/article/8277c105b38f465fa2bd4074aac1eb65
Autor:
A I Karachunsky, Yu V Rumyantseva, S N Lagoiko, C Bührer, G Tallen, O V Aleinikova, O I Bydanov, N V Korepanova, L V Baidun, T V Nasedkina, A Von Stackelberg, G A Novichkova, A A Maschan, D V Litvinov, N I Ponomareva, K L Kondratchik, E G Mansurova, L G Fechina, O V Streneva, N B Yudina, G R Sharapova, A V Shamardina, I E Gerbek, A P Shapochnik, A G Rumyantsev, G Henze
Publikováno v:
Терапевтический архив, Vol 87, Iss 7, Pp 41-50 (2015)
Aim. To determine predictors for decision-making on a differential approach to choosing glucocorticosteroids (GCS) for children and adolescents with acute lymphoblastic leukemia (ALL). Subjects and methods. The analysis covered 1064 primary patients
Externí odkaz:
https://doaj.org/article/147f5ec7da0240dfa743df8a897f13a9
Autor:
Yu V Rumyantseva, A I Karachunsky, O V Aleinikova, L G Fechina, A V Shamardina, D V Litvinov, N I Ponomareva, E G Boichenko, S A Dudkin, O V Streneva, K L Kondratchik, E G Mansurova, L M Minkina, E S Lapotentova, E V Inyushkina, N B Yudina, G P Pavlova, E V Zhukovskaya, O P Khlebnikova, S N Lagoiko, E V Basharova, R E Denisov, V D Zlobina, E S Banshchikova, K S Aslanyan, E V Kondakova, E V Tselousova, N V Myakova, T V Turobova, O V Ryskal, N F Chipsanova, S R Varfolomeyeva, A G Rumyantsev
Publikováno v:
Терапевтический архив, Vol 82, Iss 7, Pp 11-19 (2010)
Aim. To evaluate the efficiency of the original ALL-MB-2002 protocol within the multicenter study of treatment of acute lymphoblastic leukemia (ALL) in children. Subjects and methods. A total of 1873 primary patients with ALL aged 1 to 18 years, of w
Externí odkaz:
https://doaj.org/article/cfbc2ada713446ef93c73a86b57fd3bc
Autor:
M. Yu. Goroshkova, Yu. V. Rumyantseva, O. V. Aleinikova, S. A. Dudkin, L. G. Fechina, A. V. Shamardina, O. V. Streneva, K. L. Kondratchik, L. M. Minkina, E. S. Lapotentova, E. V. Inyushkina, O. B. Kozlova, E. V. Zhukovskaya, O. P. Khlebnikova, E. V. Basharova, V. N. Timofeeva, G. P. Pavlova, V. D. Zlobina, O. A. Utrobina, E. S. Banshchikova, K. S. Aslanyan, E. V. Kondakova, E. V. Tselousova, N. V. Myakova, T. V. Turobova, O. V. Ryskal, O. Yu. Fuks, V. V. Lebedev, N. F. Chipsanova, S. R. Varfolomeeva, A. I. Karachunsky
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 25-33 (2022)
The paper presents the results of a multicenter randomized study of two-dose COLI-ASP regimens in therapy of consolidation of standard risk-group (SRG) children and adolescents with acute lymphoblastic leukemia (ALL) treated by the ALL-MB-2002 protoc
Externí odkaz:
https://doaj.org/article/273ffc5c215a492e9db3020d5e11e678
Autor:
J. V. Roumiantseva, A. I. Karachunsky, O. V. Aleinikova, L. G. Fechina, A. V. Schamardina, D. V. Litvinov, N. I. Ponomareva, E. G. Boichenko, L. V. Sidorenko, S. A. Dudkin, O. V. Streneva, K. L. Kondratchik, E. G. Mansurova, L. M. Minkina, E. S. Lapotentova, E. V. Inuschkina, N. B. Yudina, G. P. Pavlova, E. V. Zhukovskaya, O. P. Chlebnikova, S. N. Lagoiko, E. V. Bascharova, R. E. Denisov, V. D. Zlobina, E. S. Banschikova, K. S. Aslanyan, E. V. Kondakova, E. V. Celousova, N. V. Myakova, T. V. Turobova, O. V. Riskal, N. F. Chipsanova, S. R. Varfolomeeva, A. G. Rumiantsev
Publikováno v:
Онкогематология, Vol 0, Iss 1, Pp 37-49 (2022)
Проанализирована значимость прогностических факторов эффективности терапии у детей с острым лимфобластным лейкозом (ОЛЛ), получающих
Externí odkaz:
https://doaj.org/article/60da326014b14be09d19043fc252c8e4
Autor:
G. A. Tsaur, T. V. Nasedkina, A. M. Popov, O. V. Kalennik, A. G. Solodovnikov, T. O. Riger, Yu. A. Yakovleva, A. S. Ivanova, A. E. Druy, O. M. Plekhanova, E. V. Shorikov, L. I. Saveliev, L. G. Fechina
Publikováno v:
Онкогематология, Vol 0, Iss 2, Pp 46-54 (2022)
Early therapy response is one of the major prognostic factors influencing an outcome of acute lymphoblastic leukemia (ALL). The purpose of the given work was to define a time point (TP) of fusion gene transcript (FGt) monitoring by reverse-transcript
Externí odkaz:
https://doaj.org/article/bccdae5e6fb84086b30c2fa0980c4bf2
Autor:
E. V. Samochatova, L. N. Schelikhova, M. B. Belogurova, A. V. Schamardina, E. V. Bascharova, D. V. Litvinov, N. V. Myakova, L. G. Fechina, O. P. Chlebnikova, E. V. Inuschkina, O. V. Riskal, P. Z. Schammasov, I. M. Yunusova, S. Yu. Umnova, D. M. Konovalov, A. G. Talalaev, J. V. Roumiantseva, A. A. Maschan
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 4-14 (2022)
Therapy results of 61 patients (children and adolescents, 2—17 years of age; a median — 8.76 years) with B-cells non-Hodgkin lymphomas III—IV stage and B-cell acute leukemia (B-NHL/B-ALL), treating according to protocol with polichemotherapy an
Externí odkaz:
https://doaj.org/article/483bc1441ecd4784874b8cf5dccf3b60
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 22:54-59
Literature data suggest that vitamin D (VD) deficiency may adversely affect many systems of the body, not only skeletal system, as believed earlier, but also central nervous system, cardiovascular system, urinary system, and immune system, which is p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c35c3dab30efa604e0959fd11beade3f
https://doi.org/10.24287/1726-1708-2023-22-2-54-59
https://doi.org/10.24287/1726-1708-2023-22-2-54-59
Autor:
M. B. Belogurova, T. V. Kotlyarova, D. Y. Kachanov, L. G. Fechina, A. N. Zaychikov, E. S. Mitrofanova, A. S. Slinin, T. V. Shamanskaya
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 21:45-52
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2e487db0069c9f54dcb351e43deef71
https://doi.org/10.24287/1726-1708-2022-21-4-45-52
https://doi.org/10.24287/1726-1708-2022-21-4-45-52
Autor:
R. N. Suprun, Yu. V. Rumyantseva, O. I. Bydanov, L. I. Zharikova, S. N. Lagoiko, V. V. Lebedev, K. L. Kondratchik, E. A. Druy, E. G. Mansurova, T. V. Asekretova, O. E. Murashkina, O. V. Aleynikova, L. G. Fechina, G. V. Bykova, N. I. Ponomareva, N. V. Myakova, A. M. Popov, Yu. V. Olshanskaya, A. N. Kazakova, D. V. Litvinov, G. A. Novichkova, A. I. Karachunskiy
Publikováno v:
Russian Journal of Pediatric Hematology and Oncology. 9:12-31
Introduction. Down syndrome (DS) is one of the most common chromosomal abnormalities. Children with DS have an increased risk of developing acute lymphoblastic leukemia (ALL). Standard therapy is usually used to treat ALL in children with Down syndro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f036e3dafc5f4f57b9d14b9e3cca4c8c
https://doi.org/10.21682/2311-1267-2022-9-3-12-31
https://doi.org/10.21682/2311-1267-2022-9-3-12-31